Value of sentinel node status as a prognostic factor in melanoma: prospective observational study.

@article{Kettlewell2006ValueOS,
  title={Value of sentinel node status as a prognostic factor in melanoma: prospective observational study.},
  author={Stephen Kettlewell and Colin Moyes and Caroline A. Bray and David A Soutar and Alan Mackay and Dominique Byrne and Taimur Shoaib and Barun Majumder and R. E. Mackie},
  journal={BMJ},
  year={2006},
  volume={332 7555},
  pages={1423}
}
OBJECTIVE To establish the prognostic value of knowledge of sentinel node status in melanoma. DESIGN Single centre prospective observational study, with sentinel nodes identified by lymphoscintigraphy, gamma probe, and intraoperative blue dye and examined by both conventional histopathology and immunopathology. SETTING Specialist surgical service in west of Scotland. PARTICIPANTS 482 patients with melanoma who consented to sentinel node biopsy in 1996-2003. MAIN OUTCOME MEASURE Time to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Sentinel lymph node biopsy in melanoma: The Oxford ten year clinical experience.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS • 2011
View 4 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Interim results of the multicenter selective lymphadenectomy trial ( MSLTI ) in clinical stage I melanoma

DL Morton, JF Thompson, AJ Cochran, R Essner, R Elashoff
J Clin Oncol • 2005

Post - surgery adjuvant therapy with intermediate doses of interferon alpha 2 beta versus observation in patients with stage 11 b / 111 melanoma ( EORTC 19852 ) : randomised controlled trial

AM Eggermont, S Suciu, +3 authors W Kruit
Lancet • 2005

Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology • 2002

High and low dose interferon alpha 2 beta in high risk melanoma : first analysis of intergroup trial E 1690 / S 9111 / C 9190

JM Kirkwood, JG Ibrahim, +3 authors MS Ernstoff
J Clin Oncol • 2000

Similar Papers

Loading similar papers…